ScreenerHero

ELAB PMGC Holdings Inc.

NAS · US · Healthcare · Biotechnology · pmgcholdings.com
3.140USD-3.98%Mkt Cap: 2.54M $P/E: —

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT pac…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap2.54M USD
Enterprise Value-2.08M USD
Revenue (TTM)2.58M USD
Gross Profit185.31K USD
Net Income (TTM)-7.75M USD
Revenue/Share19.08 USD
Last Price3.140 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees32
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA0.18
EV/Revenue-0.81
P/S1.03
P/B0.12
EPS (TTM)-1757.13
EPS (Forward)—
52W Range
2.5850% of range2671.20
52W High2671.20 USD
52W Low2.585 USD
Profitability
Gross Margin31.40%
Oper. Margin-289.98%
EBITDA Margin0.00%
Profit Margin-1313.00%
ROE-98.86%
ROA-60.21%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.93M USD
CapEx (TTM)448.25K USD
FCF Margin-160.31%
FCF Yield-162.62%
Net Debt-4.73M USD
Net Debt/EBITDA0.41
Balance Sheet
Debt/Equity0.34
Current Ratio1.36
Quick Ratio1.28
Book Value/Sh27.20 USD
Cash/Share23.42 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateAug 21, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.809.58K
Float764.19K
Insiders5.61%
Institutions3.29%
Short Interest
Short Ratio0.6d
Short % Float4.25%
Short % Out.4.25%
Shares Short34.39K
Short (prev mo.)26.59K
Technical
SMA 506.319 (-50.3%)
SMA 20070.98 (-95.6%)
Beta-0.27
S&P 52W Chg16.45%
Avg Vol (30d)63.60K
Avg Vol (10d)82.09K
Technical Indicators
RSI (14)24.6
MACD-0.9889
MACD Signal-1.0470
MACD Hist.+0.0581
BB Upper5.442 USD
BB Middle4.168 USD
BB Lower2.895 USD
BB Width61.09%
ATR (14)0.5506 USD
Vol Ratio (20d)0.33x